Table 13.11

Adjusted Patient Survival, Heart-Lung Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

		3 Months			1 Year			3 Years			5 Years
		(Tx 2002 - 2003)			(Tx 2002 - 2003)			(Tx 2000 - 2003)			(Tx 1998 - 2003)
		N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.
Total	All	57	70.5%	6.0%	57	58.2%	6.5%	130	52.7%	4.6%	222	41.3%	3.8%
Primary Diagnosis	Congenital Disease	19	67.2%	10.7%	19	45.0%	11.6%	50	49.2%	7.4%	85	39.8%	6.3%
	Primary Pulmonary Hypertension	17	79.1%	9.5%	17	79.1%	9.5%	32	70.8%	8.2%	50	56.9%	7.8%
	Cystic Fibrosis	2	49.2%	25.5%	2	49.2%	25.5%	2	47.4%	25.6%	4	22.8%	15.0%
	Emphysema/COPD	0	-	-	0	-	-	3	32.6%	19.8%	10	58.5%	15.4%
	Other	3	61.9%	23.8%	3	61.9%	23.8%	9	0.0%	0.0%	14	0.0%	0.0%
	Unknown	16	69.7%	11.0%	16	51.1%	12.1%	34	55.9%	8.3%	59	38.0%	6.9%

Source: OPTN/SRTR Data as of May 2, 2005.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Patient survival follows patients from first transplant of this type until death.Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on heart-lung transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.